Filing Details
- Accession Number:
- 0001209191-15-005906
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-01-22 17:53:08
- Reporting Period:
- 2015-01-20
- Filing Date:
- 2015-01-22
- Accepted Time:
- 2015-01-22 17:53:08
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1373707 | Tetraphase Pharmaceuticals Inc | TTPH | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1296998 | Guy Macdonald | 480 Arsenal St. Suite 110 Watertown MA 02472 | President And Chief Executive | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2015-01-20 | 10,000 | $7.94 | 60,000 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2015-01-20 | 849 | $0.87 | 60,849 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2015-01-20 | 22,030 | $2.03 | 82,879 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2015-01-20 | 1,256 | $5.80 | 84,135 | No | 4 | M | Direct | |
Common Stock | Disposition | 2015-01-20 | 34,135 | $36.59 | 50,000 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Employee Stock Option (right to buy) | Disposition | 2015-01-20 | 10,000 | $0.00 | 10,000 | $7.94 |
Common Stock | Employee Stock Option (right to buy) | Disposition | 2015-01-20 | 849 | $0.00 | 849 | $0.87 |
Common Stock | Employee Stock Option (right to buy) | Disposition | 2015-01-20 | 22,030 | $0.00 | 22,030 | $2.03 |
Common Stock | Employee Stock Option (right to buy) | Disposition | 2015-01-20 | 1,256 | $0.00 | 1,256 | $5.80 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
260,000 | 2023-05-14 | No | 4 | M | Direct | |
109,323 | 2019-09-10 | No | 4 | M | Direct | |
57,331 | 2020-09-27 | No | 4 | M | Direct | |
25,834 | 2018-08-07 | No | 4 | M | Direct |
Footnotes
- The exercise and sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 25, 2014.
- The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $35.79 to $38.095 per share. The reporting person hereby undertakes, upon request of the staff of the U.S. Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- Vested as to 25% of the original number of shares granted on 5/15/2014 and further vests as to an additional 6.25% of the original number of shares granted at the end of each successive three-month period thereafter until 5/15/2017.
- Fully vested.
- The number of derivative securities beneficially owned following the transaction reported on this Form 4 has been adjusted to reflect the additional 25,834 incentive stock options owned by the reporting person, and previously reported as a separate option owned by the reporting person, in addition to the non-qualified stock options that were previously reported in the Form 4 filed by the reporting person.